Add to ORKGOtotoxicity is a well-known complication of certain chemotherapeutic agents. There have been few reports of ototoxicity following administration of vincristine. However, vinblastine has seldom been implicated causing ototoxicity. We report a case of sudden bilateral hearing loss in a 32-year-old male patient of classical Hodgkin’s lymphoma following standard adriamycin, bleomycin, vinblastine, dacarbazine chemotherapy
Background: Fourteen million new cancer cases are reported annually, and up to 10% of those involve ...
Cisplatin is an anticancer drug used against a number of malignancies e.g. testicular cancer, ovaria...
Background: Although combined chemotherapy has increased survival rates among children with cancer, ...
Background: Vincristine, a type of vinca alkaloid, is widely used in the treatment of various childh...
Cisplatin is a potent chemotherapeutic agent that is commonly used to treat a wide variety of tumour...
International audienceHearing loss is defined as a decrease in the ability to perceive sounds which ...
Chronic myelomonocytic leukemia (CMML) was initially classified in the category of myelodysplastic s...
AbstractSudden bilateral hearing loss are seen rarely and the toxic substance exposure constitutes a...
Drug-induced ototoxicity has been known for centuries. Already in the seventeenth century, hearing l...
The risk of ototoxicity accompanying therapeutic use of aminoglycosides is clinically well recognise...
This paper reviews intriguing recent findings on the mechanisms of drug induced hearing loss caused ...
Background\ud \ud Definitive cisplatin-based is increasingly delivered as the treatment of choice fo...
Chemotherapy is often used in the conservative management of retinoblastoma. Chemotherapy drugs, whi...
© 2019, The Author(s). Introduction: Ototoxicity associated with platinum-based chemotherapy is high...
The regimen with paclitaxel and platinum compound (carboplatin or cisplatin) is the standard chemoth...
Background: Fourteen million new cancer cases are reported annually, and up to 10% of those involve ...
Cisplatin is an anticancer drug used against a number of malignancies e.g. testicular cancer, ovaria...
Background: Although combined chemotherapy has increased survival rates among children with cancer, ...
Background: Vincristine, a type of vinca alkaloid, is widely used in the treatment of various childh...
Cisplatin is a potent chemotherapeutic agent that is commonly used to treat a wide variety of tumour...
International audienceHearing loss is defined as a decrease in the ability to perceive sounds which ...
Chronic myelomonocytic leukemia (CMML) was initially classified in the category of myelodysplastic s...
AbstractSudden bilateral hearing loss are seen rarely and the toxic substance exposure constitutes a...
Drug-induced ototoxicity has been known for centuries. Already in the seventeenth century, hearing l...
The risk of ototoxicity accompanying therapeutic use of aminoglycosides is clinically well recognise...
This paper reviews intriguing recent findings on the mechanisms of drug induced hearing loss caused ...
Background\ud \ud Definitive cisplatin-based is increasingly delivered as the treatment of choice fo...
Chemotherapy is often used in the conservative management of retinoblastoma. Chemotherapy drugs, whi...
© 2019, The Author(s). Introduction: Ototoxicity associated with platinum-based chemotherapy is high...
The regimen with paclitaxel and platinum compound (carboplatin or cisplatin) is the standard chemoth...
Background: Fourteen million new cancer cases are reported annually, and up to 10% of those involve ...
Cisplatin is an anticancer drug used against a number of malignancies e.g. testicular cancer, ovaria...
Background: Although combined chemotherapy has increased survival rates among children with cancer, ...